Raleigh Capital Management Inc. Pacira Bio Sciences, Inc. Transaction History
Raleigh Capital Management Inc.
- $232 Million
- Q2 2024
A detailed history of Raleigh Capital Management Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 537 shares of PCRX stock, worth $7,034. This represents 0.01% of its overall portfolio holdings.
Number of Shares
537Holding current value
$7,034% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
301Shares Held
51.5MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$105 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$66.6 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$28.3 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$27.1 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$24.9 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $600M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...